 |
 |
 |
| |
Third-Generation INSTI VH4524184 (VH-184) Has an Enhanced Resistance Profile vs Bictegravir
|
| |
| |
CROI Feb 22-25 2026 Denver
Mark Underwood,1 Jerry L. Jeffrey,1 Luise Rogg,1 Lesley Kahl,2 Takahiro Seki,3 Joseph Horton,4 Jon Collins,1 Martin Gartland1
1ViiV Healthcare, Durham, NC, USA; 2ViiV Healthcare, London, UK; 3Shionogi & Co., LTD., Osaka, Japan; 4Parexel International, Durham, NC, USA





|
| |
|
 |
 |
|
|